Nonetheless, they showed that the HIF-2α inhibitor alone or in combination with drugs in patient-derived primary colon cancer cells was able to overcome resistance to 5-fluorouracil (5-FU) or mTOR inhibitor, CCI-779 (94). The gene discussed is MTOR; the disease is malignant colon neoplasm.